About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Pharmacogenetics and Genomics
›
Top Articles
Pharmacogenetics and Genomics
Pharmacology
(top 60%)
Impact Factor
(top 60%)
extended IF
135
(top 2%)
H-Index
325
authors
1.1K
papers
77.4K
citations
4.3K
citing journals
21.9K
citing authors
Most Cited Articles of Pharmacogenetics and Genomics
Title
Year
Citations
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
1996
2.4K
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders
1996
1.5K
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence
1997
927
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants
2004
765
Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data
2002
585
The genetic determinants of the CYP3A5 polymorphism
2001
557
The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism
1996
549
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver
2001
503
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele
1997
474
Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9
1994
444
Biochemistry and molecular biology of the human CYP2C subfamily
1994
436
The AH-receptor: genetics, structure and function
1993
404
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid
2001
400
Higher plant metabolism of xenobiotics: the 'green liver' concept
1994
385
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites
1992
380
Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes
2000
371
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients
2004
368
Noninvasive tests of CYP3A enzymes
1994
364
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)
2004
358
Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants
2004
348
Nomenclature for human CYP2D6 alleles
1996
348
The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells
2001
341
Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene
2003
335
MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity
2001
335
Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method
2000
329
previous
1998
1999
2000
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.